GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
GH Research PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026
$18.28+0.13 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $1.22B
- P/E (TTM)
- –
- Dividend yield
- –
GH Research statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | GH Research | Industry median |
|---|---|---|
| Market Cap | $1.13B | $166.30M |
| Enterprise Value | $788.84M | $88.19M |
Income (trailing twelve months)
| Measure | GH Research | Industry median |
|---|---|---|
| Operating Income | -$71.49M | -$21.40M |
| Pretax Income | -$62.27M | -$14.34M |
| Net Income | -$62.27M | -$22.46M |
| EBITDA | -$71.13M | -$16.91M |
| EPS (Diluted) | -$1.00 | -$0.83 |
Returns
| Measure | GH Research | Industry median |
|---|---|---|
| Return on Assets (ROA) | -18.2% | -40.9% |
| Return on Capital Employed (ROCE) | -19.9% | -38.1% |
Balance sheet
| Measure | GH Research | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $345.05M | $61.43M |
| Net Cash (Debt) | $345.05M | $15.35M |
| Net Cash Per Share | $5.56 | $0.66 |
| Working Capital | $355.97M | $76.81M |
Financial position
| Measure | GH Research | Industry median |
|---|---|---|
| Current Ratio | 28.70 | 3.34 |
| Quick Ratio | 26.85 | 2.44 |
| Interest Coverage | -257.14 | -6.26 |
Cash flow (trailing twelve months)
| Measure | GH Research | Industry median |
|---|---|---|
| Operating Cash Flow | -$51.70M | -$12.35M |
| Capital Expenditures | -$138.00K | -$1.08M |
| Free Cash Flow | -$51.84M | -$20.22M |
| FCF Per Share | -$0.84 | -$0.42 |
Efficiency
| Measure | GH Research | Industry median |
|---|---|---|
| Profits Per Employee | -$853.01K | -$703.34K |
| Employee Count | 73 | 74 |
Dividends and yields
| Measure | GH Research | Industry median |
|---|---|---|
| Earnings Yield | -5.49% | -23.3% |
| FCF Yield | -4.57% | -8.72% |
| Buyback Yield | 2.82% | -0.59% |
| Shareholder Yield | 2.82% | 0.00% |
Shares
| Measure | GH Research | Industry median |
|---|---|---|
| Shares Outstanding | 62,029,400 | 58,127,000 |
| Shares Change (YoY) | 12.7% | 10.9% |
| Float | 33,760,800 | 49,136,700 |
| Shares Held by Insiders | 45.6% | 11.6% |
Taxes
| Measure | GH Research | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | GH Research | Industry median |
|---|---|---|
| Altman Z-Score | 52.72 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from GH Research's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.